Literature DB >> 27652196

A case report of extramedullary haematopoeisis in lumbosacral region presenting as cauda equina syndrome.

Shardul Soman1, G D Tharadara2, Naitik Chhatrala2, Shubham Jain2.   

Abstract

INTRODUCTION: Extramedullary hematopoeisis (EMH) is defined as formation of blood cells outside the bone marrow. It occurs most commonly in the liver and spleen in patients having disorders that lead to chronic anaemia. EMH in spinal canal is a very rare site and cauda equina syndrome due to EMH has very few cases presented in literature. CASE
PRESENTATION: A 28 year old male patient presented with complain of incontinenance of bladder and bowel along with saddle anaesthesia from 10 days. Patient was a known case of beta-thalassemia intermedia. And MRI scan of the spine showed multiple well circumscribed, enhancing lesions in the epidural space extending from L5 to S3 and resulting in compression of the cauda equina. Patient underwent posterior neural decompression by a laminectomy from L5 to S3. At 3 months follow up patient had partial recovery of his bladder control and complete recovery of sensation.
CONCLUSION: EMH should be recognized early on the basis of clinical features and MRI findings. The various modalities available for treatment of such cases includes blood transfusion, low dose radiotherapy, hydroxyurea and surgical decompression. There are very few cases noted in the literature of such phenomenon in the lumbosacral spine. In cases of acute presentations like cauda equine surgical decompression is a treatment modality of choice.

Entities:  

Keywords:  compression; extramedullary; hematopoiesis; thalassemia

Year:  2016        PMID: 27652196      PMCID: PMC5027816          DOI: 10.14444/3025

Source DB:  PubMed          Journal:  Int J Spine Surg        ISSN: 2211-4599


  13 in total

1.  [Compression of the spinal cord due to proliferation of bone marrow in epidural space in a splenectomized person with Cooley's disease].

Authors:  I GATTO; V TERRANA; L BIONDI
Journal:  Haematologica       Date:  1954       Impact factor: 9.941

2.  Effect of radiotherapy on symptoms due to heterotopic marrow in beta-thalassaemia.

Authors:  C Papavasiliou; P Sandilos
Journal:  Lancet       Date:  1987-01-03       Impact factor: 79.321

3.  Mass-like extramedullary hematopoiesis: imaging features.

Authors:  Andrew W Ginzel; Mark J Kransdorf; Jeffrey J Peterson; Hillary W Garner; Mark D Murphey
Journal:  Skeletal Radiol       Date:  2011-11-20       Impact factor: 2.199

4.  Spinal cord compression in homozygous beta-thalassemia intermedia.

Authors:  E Cardia; S Toscano; G La Rosa; C Zaccone; D d'Avella; F Tomasello
Journal:  Pediatr Neurosurg       Date:  1994       Impact factor: 1.162

5.  Extramedullary paraspinal hematopoiesis in thalassemia: CT and MRI evaluation.

Authors:  J Tsitouridis; S Stamos; E Hassapopoulou; K Tsitouridis; P Nikolopoulos
Journal:  Eur J Radiol       Date:  1999-04       Impact factor: 3.528

6.  Paraplegia due to extramedullary hematopoiesis in thalassemia treated successfully with radiation therapy.

Authors:  Monica Malik; Lakshmi S Pillai; Nidhi Gogia; Tarun Puri; M Mahapatra; Daya Nand Sharma; Rajat Kumar
Journal:  Haematologica       Date:  2007-03       Impact factor: 9.941

7.  Imaging of spinal cord compression due to thoracic extramedullary haematopoiesis in myelofibrosis.

Authors:  A Guermazi; Y Miaux; J Chiras
Journal:  Neuroradiology       Date:  1997-10       Impact factor: 2.804

8.  Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis.

Authors:  H Cario; M Wegener; K-M Debatin; E Kohne
Journal:  Ann Hematol       Date:  2002-08-15       Impact factor: 3.673

Review 9.  Spinal cord compression in beta-thalassemia: case report and review of the literature.

Authors:  S A Salehi; T Koski; S L Ondra
Journal:  Spinal Cord       Date:  2004-02       Impact factor: 2.772

10.  Spinal cord compression due to extramedullary haemopoiesis in myelofibrosis.

Authors:  G Cook; R A Sharp
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.